Welcome to the Money blog, Sky News' consumer and personal finance hub. Today: declaring some medical conditions increases ...

The mass retailer lowered its guidance for the full year, announced the departure of multiple executives and launched a new ...

President Donald Trump's tariffs are widening the gap between market-leader Walmart and Target, the companies' latest ...

Target has reduced its full-year sales forecast, with its CEO signaling price rises over tariffs have not been ruled out and ...

What on Earth is going on at the Bank of England? The question is as valid today as it was three years ago, when the UK was ...

The retailer's CEO attributed the results to weakness in discretionary spending, declining consumer confidence, uncertainty ...

Target is making another play at incentivizing its highest reward tier by offering markup-free prices on same-day delivery ...

Circle 360 is Target's premium membership program, costing shoppers $99 per year, for which they get access to free, ...

The latest US consumer inflation report revealed easing prices in April as euphoria over the US-China trade truce faded.

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

On Wednesday, BofA Securities revised its price target for Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO) shares, lowering it to DKK850 from the previous DKK910. Despite the reduction, the firm ...

Accompanying this change, they also revised the price target downward from DKK940.00 to DKK910.00. The downgrade follows a reassessment of the company’s financial outlook, particularly focusing on its ...